TITLE

Vysis Ships Genosensor Microarray System for Genomic Research

PUB. DATE
March 2000
SOURCE
Worldwide Biotech;Mar2000, Vol. 12 Issue 3, p3
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Reports that Vysis Inc. has initiated customer shipments of its GenoSensor Microarray System, which allows researchers to identify key genomic correlation in disease occurrence and outcome.
ACCESSION #
2889683

 

Related Articles

  • Biotech firm fails to fire up investors. Murphy, H. Lee // Crain's Chicago Business;10/05/98, Vol. 21 Issue 40, p14 

    States that Vysis Inc. a specialist in the field of genomics biotechnology has disappointed investors since its initial public offering on February 4, 1998, which raised $33 million for the company. Why analysts do not expect Vysis of Downers Grove, Illinois to show profit before 1999; Vysis'...

  • Stock report.  // Crain's Chicago Business;11/16/98, Vol. 21 Issue 46, p59 

    Presents information on stock trading in Chicago, Illinois, as of the week ending November 16, 1998. Major stock gainers and losers; Earnings of Vysys Inc.

  • Genetic-treatment market projection. Teresko, John; Stevens, Tim // Industry Week/IW;12/5/94, Vol. 243 Issue 22, p33 

    Reports on projections in the genetic-disease-management market made by Vysis Inc. Categories; Amount of investments.

  • Vysis Acquires Intellectual Property of Aprogenex.  // Worldwide Biotech;Sep99, Vol. 11 Issue 9, p7 

    Reports the acquisition of Aprogenex's intellectual property portfolio by Vysis, Inc., a genomic disease management company. Inclusion of European and Japanese counterpart patents and patent application; Coverage of the portfolio; Remarks from John Bishop, president and chief executive officer...

  • BP Places Vysis On the Selling Block. Roberts, Ricardo // Mergers & Acquisitions Report;7/23/2001, Vol. 14 Issue 29, p5 

    Reports on the decision of BP plc to sell Dowers Grove, Illinois-based Vysis Inc. in the U.S. Background of Vysis; Reason for selling Vysis; Plan of Abbott Laboratories to acquire Vysis.

  • Stock report.  // Crain's Chicago Business;02/21/2000, Vol. 23 Issue 8, p63 

    Presents data concerning the stock market performance of companies in Chicago, Illinois as of February 21, 2000. Includes Vysis Inc.; Salton Inc.; Akorn Inc.

  • Tech stocks take brunt of market's dip. Murphy, H. Lee // Crain's Chicago Business;07/17/2000, Vol. 23 Issue 30, p41 

    Reports on the decline of the stock value of high technology companies in Chicago, Illinois. Largest losers for the first half of 2000; Inquiry made by the New York Stock Exchange about trading activity regarding the stocks of Entrade Inc.; Rise of the stock value of genomic disease management...

  • Industry news.  // MLO: Medical Laboratory Observer;Jul2000, Vol. 32 Issue 7, p76 

    Presents news briefs on medical laboratories in the U.S. as of July 2000. Settlement of a class-action suit between Quest Diagnostics Inc. and Damon Clinical Laboratories; Collaborative agreement signed by Vysis Inc. and Genentech Inc.; Expansion of reimbursement for Digene Corporation's Hybrid...

  • HER-2 DNA probe kit is OK'd.  // Drug Store News;1/11/99, Vol. 21 Issue 1, pCP16 

    Cites the United States Food and Drug Administration's approval of Vysis Inc.'s Path Vysion test, a HER-2 DNA probe kit to detect and quantify the HER-2 gene in breast cancer patients.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics